LLS care support program for blood cancer patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at whether LLS services and support improve outcomes and the day-to-day experience of care for people with leukemia, lymphoma, myeloma, MDS, or MPN. It’s mainly about matching you to the right support and following your progress for 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (or had and it came back) leukemia, lymphoma, myeloma, MDS, or MPN
- You’re getting treatment now, starting soon, or you recently had a stem cell transplant or CAR-T therapy
- Your current or planned treatment timing must match one of the study timelines
- You are not currently using any LLS programs or services
- You can be followed by the study team for 6 months
- You speak English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
This study creates a structured follow-up program for children and teens who have finished treatment for blood cancers like leukemia or lymphoma. It aims to help survivors stay healthy and catch any late effects of treatment early.
This study tests a communication training program for providers who care for people with large B-cell lymphoma. The goal is to improve how clinicians talk with patients, especially during difficult treatment periods like relapse.
This study aims to improve communication and strengthen a child’s “medical home” (the main care team and coordination) for Spanish-speaking families. It focuses on families receiving cancer care at the Center for Cancer and Blood Disorders (CCBD).
This study is collecting long-term follow-up information from people diagnosed with certain blood and bone marrow conditions. It may help doctors understand what happens over time and improve future care, but you’re mainly contributing data rather than receiving a new treatment.
This study tests a personalized exercise program for people with certain cancers (lung, colorectal, breast, CLL, or multiple myeloma) who are on specific treatments. The goal is to see if tailored physical activity improves your health and well-being during cancer care.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.